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Structure of the merozoite surface protein 1 
from Plasmodium falciparum
Patricia M. Dijkman1,2*†, Tanja Marzluf3,4, Yingyi Zhang1,2‡, Shih-Ying Scott Chang1,2, 
Dominic Helm4, Michael Lanzer3, Hermann Bujard5,6, Mikhail Kudryashev1,2*
The merozoite surface protein 1 (MSP-1) is the most abundant protein on the surface of the erythrocyte-invading 
Plasmodium merozoite, the causative agent of malaria. MSP-1 is essential for merozoite formation, entry into and 
escape from erythrocytes, and is a promising vaccine candidate. Here, we present monomeric and dimeric struc-
tures of full-length MSP-1. MSP-1 adopts an unusual fold with a large central cavity. Its fold includes several 
coiled-coils and shows structural homology to proteins associated with membrane and cytoskeleton interactions. 
MSP-1 formed dimers through these domains in a concentration-dependent manner. Dimerization is affected by 
the presence of the erythrocyte cytoskeleton protein spectrin, which may compete for the dimerization interface. 
Our work provides structural insights into the possible mode of interaction of MSP-1 with erythrocytes and estab-
lishes a framework for future investigations into the role of MSP-1 in Plasmodium infection and immunity.
INTRODUCTION
With 229 million reported cases and 409,000 deaths in 2019 world-
wide and more than half of the world’s population at risk, malaria 
remains a great burden to global health (1). Earlier reductions in 
incident rates have leveled off between 2015 and 2019 (1), making 
the development of a vaccine as vital as ever. Merozoites are the 
erythrocyte-infecting form of the malaria-causing Plasmodium par-
asite, and merozoite surface proteins (MSPs) show potential as 
malaria vaccines [reviewed by Beeson et al. (2)]. After erythrocyte 
invasion, merozoites replicate within the parasitophorous vacuole 
(PV) for ~48 hours in the case of Plasmodium falciparum, until they 
egress by sequential rupture of the PV membrane (PVM) and host 
cell membrane and go on to invade new host cells within minutes 
(3). In this short time window, the merozoite surface is exposed to 
the immune system. Several integral and peripheral MSPs (4, 5) 
form a thick fibrillar coat on the merozoite surface, MSP-1 being 
the most abundant (5). Antibodies targeting MSP-1 are found in 
sera of individuals from malaria-endemic regions and have been 
shown to confer some immunity (6–8). Thus, MSP-1 is considered 
a prime candidate antigen for vaccine development (9). It consists 
of four subunits, p83, p30, p38, and p42, which are held together 
noncovalently (Fig.  1A). A glycosylphosphatidylinositol (GPI) 
anchor links the complex to the membrane via the p42 subunit. 
MSP-1 is produced by subtilisin-like protease 1 (SUB-1) cleavage of 
a ~190-kDa precursor protein (p190) just before erythrocyte egress. 
In a second processing step by SUB-2 during erythrocyte invasion, 
p42 is cleaved into p33 and p19; the latter remains attached to the 
parasite surface via its GPI anchor, while the rest of the complex is 
shed (10). The MSP-1 complex is known to interact with a range of 
other merozoite proteins, including MSP-3, MSP-6, MSP-7, and 
MSP-9, and MSP Duffy binding-like (MSPDBL)–1 and MSPDL-2 
(11–13), forming various different complexes on the parasite sur-
face (14–16). MSP-7 associates with MSP-1 immediately after trans-
lation (17), while other MSPs bind to the complex after maturation 
(11, 18, 19). Although the functional role of MSP-1 is not yet well 
understood, it is essential to Plasmodium development given that 
MSP-1 knockdown mutants could not be generated (20, 21). It is 
thought to play a role in early erythrocyte attachment and invasion 
(22); MSP-1 has been shown to bind the erythrocyte surface pro-
teins glycophorin A (GPA) (23) and band 3 (15), the latter being 
essential in the merozoite invasion process (23). Other studies failed 
to detect direct binding of red blood cells (RBCs) by MSP-1 itself 
but reported interactions with other components of the MSP-1 
complex, specifically MSPDBL-1, MSPDBL-2, MSP-6, and MSP-9, 
although the RBC host receptors of these components remain 
unknown, and conflicting data were reported for MSP-6 (12–15). 
MSP-1 also interacts with the erythrocyte cytoskeleton protein 
spectrin (24, 25) and plays a role in egress (25). Antibodies targeting 
all MSP-1 subunits (14,  26), as well as some associated MSPs 
(11, 13), have been shown to inhibit parasite growth in RBC cul-
tures. Antibodies targeting the p19 subunit have received particular 
scrutiny (10,  20), although contradictory reports exist regarding 
their ability to prevent disease (6), and immunization trials using 
only p42 were unsuccessful in inducing significant protection against 
malaria (27). Given the additive inhibitory effect that was observed 
for antibodies targeting the different MSP-1 subunits in in  vitro 
parasite growth assays (26), full-length MSP-1 may be a better vac-
cine antigen. A recent phase 1a clinical trial reported promising im-
munogenicity of a full-length recombinant MSP-1 “heterodimer” 
composed of two peptide chains corresponding to the N- and C- terminal 
“halves” of MSP-1, p83/30 and p38/42, respectively (hdMSP-1; 
Fig. 1A) (9), which was previously shown to assemble in the same 
manner as the native MSP-1 complex (28).
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Despite its clinical relevance, structural information on MSP-1 is 
sparse and limited to the C-terminal epidermal growth factor (EGF)–
like domain consisting of subunit p19 (29, 30) and global mapping 
of intersubunit interactions (28). As expected from secondary struc-
ture prediction, circular dichroism reports a largely -helical struc-
ture with a significant portion of unstructured regions (25), which 
may explain the difficulty in obtaining well-diffracting crystals of 
MSP-1. More detailed knowledge about the structure of MSP-1 may 
aid in elucidating its essential role in Plasmodium infectivity.
RESULTS
Global architecture of MSP-1
Using single-particle cryo–electron microscopy (cryo-EM), we solved 
the structures of full-length MSP-1 from P. falciparum, the deadliest 
and most prevalent of the Plasmodium spp. infecting humans (1). 
MSP-1 was produced recombinantly as a heterodimer (hdMSP-1; 
Fig. 1A) in the absence of any of the other natively associated MSPs, 
as used in the aforementioned successful phase 1a clinical trial (9), 
using the previously described MSP-1D construct based on the 
P. falciparum strain 3D7 (28). Structural analysis was performed for 
both hdMSP-1 and its fully SUB-1–processed form (henceforth 
designated MSP-1; Fig. 1A and fig. S1). The data showed continu-
ous flexibility (movie S1) and yielded several subtly different 
conformations (fig. S2 and table S1). Specifically, we solved six 
monomeric structures from the MSP-1 dataset, at nominal resolu-
tions ranging from 3.1 to 3.6 Å and two dimeric structures from the 
hdMSP-1 dataset at nominal resolutions of 3.3 and 3.6 Å, which 
were used to build atomic models de novo (figs. S2 to S4). The highest- 
resolution monomeric structure was designated as the main confor-
mation and is used for further analysis here.
MSP-1 has no sequence orthologs outside of Plasmodium and 
adopts an unusual three-dimensional (3D) architecture with a cen-
tral cavity, which is likely to face away from the parasite surface 
(Fig. 1B). The monomer consists of 37  helices (Fig. 1C), which can 
be roughly divided into two interconnected domains found on ei-
ther side of the cavity (Fig. 1, B and C). On one side, p38 and p42 
form a helical bundle (H30 to H37) made up of left-handed coiled coils, 
which we term the coiled-coil domain (Figs. 1, B and C, and 2A). 
Flexible structure alignment (31) identified similarity to BAR/IMD 
domain-like and signal transducer and activator of transcription 
(STAT)–like t-snare folds, which are associated with membrane 
Fig. 1. Global architecture of MSP-1. (A) Schematic of MSP-1 precursor protein (p190) and production of MSP-1 by SUB-1 cleavage. The canonical cleavage sites are in-
dicated with arrows. The MSP-1 heterodimer (hdMSP-1) used here comprises the N- and C-terminal halves of MSP-1. The various domains are indicated by black boxes. 
Hatching indicates regions that were not resolved in the EM maps. (B) EM maps of the main conformations of MSP-1 (monomer, left) and hdMSP-1 (dimer, right). Top: Side 
view of presumed positioning with respect to the merozoite membrane. The EGF-like domain was not resolved here; a previously determined structure (29) is shown in 
gray surface representation for reference. Red density corresponds to the loop following H34 and was only resolved for hdMSP-1 (see also fig. S8A). (C) Topology of the 
main conformation of MSP-1. Red numbers correspond to the number of unresolved amino acids at the indicated loops/domain.
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and cytoskeleton interactions (fig. S5). A flexible domain, which we 
term the wing domain, made up of the shorter N-terminal  helices 
of p83 (H1 to H12) is found on the opposite side of the central cavity 
(Figs. 1, B and C, and 2A). The EGF-like domain that makes up the 
C-terminal part of p42 (p19) was not resolved and is probably con-
nected to the rest of the protein via a flexible linker including a 
region with no predicted secondary structure (Fig. 1, B and C, and 
figs. S6 and S7). The wing domain and the coiled-coil domain are 
held together via intersubunit interactions mediated by long helices 
extending outward from each domain and p30. The largest inter-
subunit contact surface is found between p30 and p38 (2900 ± 100 Å2, 
average of all MSP-1 conformations). The 67–amino acid–long H30 
of p38 extends from the coiled-coil domain on one end of the central 
cavity to the opposite end, where it makes extensive contacts with 
H24 of p30, stabilized further by interactions with helices H26 to H29 
that wrap around the H24/30 helix pair (Fig. 2). In addition, a long 
left-handed coiled coil made up of H14 to H18 of p83 kinks around the 
H24/30 pair and extends from the edge of the wing domain to the 
bottom end of the coiled-coil domain on the opposite side of cavity 
where H17 and H18 contact p42 at the H35-36 loop and H37 (Fig. 2; 
total buried surface 970 ± 70 Å2).
Conformational flexibility
The highest degree of conformational flexibility was observed in the 
wing domain, and the solved conformations differed mainly in the 
position of this domain relative to the coiled-coil domain (Fig. 3, 
fig. S2, and movie S1). Consequently, the local resolution of the 
maps was lowest in this domain (fig. S3, E and F), and local refine-
ment of the wing domain was performed to improve the map and 
aid model building of this region (figs. S2A, S3G, and S4A). In addi-
tion, cross-links between peptides from the wing domain observed 
by cross-linking mass spectrometry (XL-MS) were consistent with 
the model (fig. S4D). Nevertheless, side-chain density remained weak 
in certain regions (in particular, for H10 and H11), and the residual 
uncertainty in the model in this region is reflected in the relatively 
high local model B-factors (fig. S4C).
Because of the continuous nature of the intrinsic flexibility of 
MSP-1, classification of the data into a limited number of classes led 
to slightly different resolved conformations for the MSP-1 and 
hdMSP-1 wing domains. No further notable differences were ob-
served between the protomers of the dimeric hdMSP-1 and the mo-
nomeric MSP-1 forms. The only exception is found in the pocket 
between H30 and H35 (fig. S8A). Here, we observe density in the 
hdMSP-1 maps that most likely corresponds to the loop between 
H34 and H35 containing the p38/p42 SUB-1 processing site, although 
the density is not clear enough to allow unambiguous model build-
ing (Fig. 1B and fig. S8A). No clear density was observed in this 
pocket for the SUB-1–treated MSP-1 sample where this loop was 
cleaved, and thus likely to be less restrained than in the hdMSP-1 
sample where it is not cleaved (Fig. 1B and fig. S8A). The p38/p42 
processing has been shown to be critical for parasite viability (25). 
Thus, the absence of global (resolved) structural changes be-
tween the hdMSP-1 and fully processed MSP-1 samples suggests 


















































































































































Fig. 2. Atomic model of MSP-1. (A) Atomic model built for the main conformation of MSP-1. Different subunits are colored in the same manner as in Fig. 1. (B) Examples 
of intersubunit interactions holding the complex together. Hydrogen bonds and salt bridges are indicated by dotted lines.
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might be due to local differences. For example, the loop itself might 
interact with crucial erythrocyte or parasite targets that require this 
loop to be “released” from the H30/35 pocket; alternatively, the 
pocket itself might be an important binding site that is blocked by 
the H34-35 loop before its cleavage and becomes accessible once the 
loop is released upon processing. The other SUB-1 processing site 
that remains intact in hdMSP-1 (p83/p30) is located in an unstruc-
tured loop between H19 and H20 and was not resolved in any of the 
structures.
Conserved and variable regions of MSP-1
Because the MSP-1 sequence varies among P. falciparum strains, 
the question arises whether the structure of MSP-1 from other 
strains would differ from the structures presented here. The MSP-1 
sequence can be divided into 17 blocks based on sequence variabil-
ity as first described by Tanabe and co-workers (32) (Fig. 4A and 
fig. S6). They noted that the primary structure of P. falciparum 
MSP-1 has a dimorphic nature, and isoforms from different 
P. falciparum strains were broadly classified as belonging to one of 
two variants, termed K1 and MAD20 based on two representative 
isolates (32). Highest sequence homology was found for blocks 1 
(comprising H1), 3 (H2 to H10), 5 (H11 and H12), 12 (H30 and H31), 
and 17 (the EGF-like domain; Fig. 4A). A similar pattern of MSP-1 
sequence conservation is observed for MSP-1 isoforms from different 
Plasmodium spp. (Fig. 4B and fig. S7). The flexible p83 wing domain 
consists of a conserved core, composed of helices H5 to H7, H9, and 
H12 (Fig. 4, A and B). The core of the coiled-coil domain, made up of heli-
ces H31 to H33 and H35, also shows relatively high sequence homology 
across P. falciparum strains and Plasmodium spp. (Fig. 4, A and B). 
The most polymorphic region (block 2, 65 amino acids in MSP-1D) 
is located between H1 and H2 in the wing domain, is predicted to be 
unstructured (fig. S6), and was not resolved in the EM maps (Fig. 4A). 
Likewise, the second oligomorphic region (block 4) contains a pre-
dicted unstructured stretch of 16 amino acids between H10 and H11 
at the edge of the wing domain that was also not resolved (Fig. 4A 
and figs. S6 and S7). This is echoed in blocks 6, 8, 10, 14, and 16, 
where unresolved (predicted unstructured) loops corresponded to the 
most variable regions (Fig. 4A and figs. S6 and S7). While the re-
solved parts of blocks 6 (H13 to H17), 10 (H26 to H30), and 16 (H35 
to H37) also contain dimorphic regions, they show comparatively 
higher homology between different P. falciparum isolates and other 
Plasmodium spp. relative to the loop regions (Fig. 4A and figs. S6 
and S7). Together, these observations suggest that the highest se-
quence variability is found in the flexible loop regions and that the 
global architecture of MSP-1 observed here may be conserved be-
tween different genotypes.
Monomer-dimer equilibrium
While MSP-1 is often depicted as monomeric (13, 25), dimeric 
forms of MSP-1 have previously been detected in detergent-resistant 
membranes of P. falciparum 3D7 schizonts by native polyacryl-
amide gel electrophoresis (PAGE) and chemical cross-linking (33). 
Here, both monomeric and dimeric forms were observed for MSP-1 
and hdMSP-1, with 2D classification of different (control) EM data-
sets yielding varying fractions of dimer and monomer classes (fig. 
S8, B and C). The hdMSP-1 datasets used for high-resolution 3D 
reconstruction yielded a larger fraction of dimer classes (53 to 100% 
dimer; fig. S8C) compared to the dataset used for the SUB-1– 
processed MSP-1, which appeared to predominantly yield mono-
mer classes (only 4% dimer; fig. S8B), supported by the apparent 
molecular weight of the samples used, gauged by size-exclusion 
chromatography (SEC; fig. S1A). Note that a smaller control dataset 
of a second MSP-1 sample yielded predominantly dimeric 2D class 
averages (89% dimer; fig. S8B) and a corresponding higher molecular 
weight estimate by SEC (fig. S1A), suggesting that SUB-1–processed 
MSP-1 is not monomeric per se. Microscale thermophoresis (MST) 
showed that in solution dimerization is concentration dependent 
with a dissociation constant (KD) of 60 ± 10 and 30 ± 20 nM for 
hdMSP-1 and MSP-1, respectively (Fig. 5A), suggesting that there is 
no significant difference in the dimerization propensity of the two 
MSP-1 forms, and the difference in monomer-to-dimer ratio ob-
served in the EM data may have been introduced during sample or 
grid preparation. Given the observed low KD and high local concen-
tration of MSP-1 on the merozoite surface, MSP-1 can be expected to 
form dimers on the parasite surface, as was observed for MSP-1 from 
P. falciparum 3D7 (33) on which the construct used here is based.
Whether or not MSP-1 forms dimers on the parasite surface is of 
interest because this could potentially shield the dimerization inter-
face to some extent from immune detection. Dimerization is medi-



























Fig. 3. Flexibility of MSP-1. (A) Main conformation of MSP-1 and (B) conformation 1 of hdMSP-1 shown in colored cylinders with only silhouettes shown for alternative 
conformations 1 to 5 of MSP-1 and conformation 2 of hdMSP-1. Monomeric structures are aligned on H24 (residues 859 to 890) chosen for the low local B-factor (see fig. 
S4C). Superpositions of the corresponding EM maps are shown in fig. S2 (A and B).
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1100 ± 90 Å2 to the total dimerization interface, with contacts be-
tween p38 and p42 adding 250 ± 20 Å2 (average of both dimer con-
formations; Fig. 5, B to E). Most interprotomer contacts are found 
between helices H14 (p83) and H37 (p42), which show patches of 
complementary surface charge (Fig. 6). Salt bridges (H490-D1515, 
K468-E1534, and K471-D1533) and various polar (e.g., Q494-N1508, 
N475-D1527, and N475-N1526) and hydrophobic interactions 
(e.g., K479-A1523) hold the helices together (Fig. 5C). In addition, 
contacts are observed between the H27-28 loop of p38 and H37 
(F1014-V1537 and salt-bridge D1011-K1541) and H17 (p83; 
N1010-N611; Fig. 5D). While all structural elements involved in 
dimerization fall within the dimorphic sequence blocks described 
by Tanabe et al. (32) (blocks 6, 10, and 16; Fig. 4A and fig. S6), a 
number of residues involved in the dimerization interface are 
conserved between different isolates (Fig. 5E). For most other residue 
pairs involved, the other genotypes could still allow favorable inter-
protomer contacts (Fig. 5E). Thus, dimerization may occur through the 
same interface in other P. falciparum genotypes. Other Plasmodium 
spp. show higher sequence variability (Figs. 4B and 5E and fig. S7), 
and it is unclear whether dimerization would be conserved across 
the genus.
Antibodies directed against a region encompassing H11 to H16, 
which includes the dimerization interface H14, are associated with 
protection against P. falciparum malaria in adolescents from Mali 
(34). Furthermore, in the recent vaccine trial by Blank et al. (9) us-
ing hdMSP-1, epitopes were identified on H14, the H27-28 loop, 
and H37, which elicited immunoglobulin G (IgG) antibody re-
sponses putatively associated with inhibiting parasite growth in vitro 
(Fig.  7 and fig. S9). It is possible that these antibodies would 
destabilize the dimer, although whether this underlies their protec-
tive action remains an open question.
MSP-1 domains involved in erythrocyte interactions 
and immunogenicity
As discussed in the introduction, MSP-1 has been shown to interact 
with erythrocyte components (15, 23–25), as well as a range of other 
merozoite proteins (11–13, 15, 17), forming various different com-
plexes on the parasite surface (14–16). The molecular details of 
these interactions remain unclear. Given that the core of the flexible 
wing domain does not participate in the stabilization of the MSP-1 
complex itself, its relatively high degree of conservation suggests 
that this domain may play a role in these interactions, as previously 
proposed by Kauth et al. (28). In support of this hypothesis, anti-
bodies against the p83 subunit that makes up this domain were par-
ticularly effective in inhibiting infection of erythrocytes by malaria 
parasites in in vitro assays (26). The p83 subunit was furthermore 
identified as a major target of opsonizing antibodies in sera from 
semi-immune individuals from Burkina Faso (35). While p83 is 
indeed also known to bind other MSPs [such as MSP-7, MSPDBL-1, 
and MSPDBL-2 (11, 13, 17)], an antibody targeting p83 inhibited 
parasite growth without affecting complex formation with these 
MSPs (14), suggesting that p83 is important for infection not only 
as a binding site for other MSPs but also, in particular, through its 
direct interaction with erythrocytes. Notably, residues 232 to 278 
(in MSP-1D numbering) of the p83 subunit, encompassing H6 to H8 
(Fig. 8A), were shown to interact with a Glu-rich extracellular 
region of GPA on the erythrocyte surface (23). The positively 








































































Fig. 4. Sequence variability of MSP-1. (A) Graphical representation of the primary structure of MSP-1, indicating the resolved helices (top), and division of the sequence 
in 17 blocks based on sequence variability of the P. falciparum MSP-1 as determined by Tanabe et al. (32) (bottom). Hatching indicates regions that were not resolved in 
the EM maps. Green blocks correspond to high sequence variability, and purple blocks correspond to high sequence conservation. (B) MSP-1 sequence conservation is 
mapped onto the main conformation derived for MSP-1 using all 46 Plasmodium MSP-1 genes from various species available from PlasmoDB (63). Green thin tubes indicate 
high sequence variability, and thick purple tubes indicate high sequence conservation. Areas for which there are insufficient homologous sequence data are colored gray.
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be electrostatic (Fig. 6). Deletion of GPA reduced but did not com-
pletely abrogate parasitemia (23). Blank and co-workers (9) identi-
fied two conserved epitopes on H8, which elicited an IgG antibody 
response putatively associated with inhibiting parasite growth 
in vitro (Fig. 7).
Other MSP-1 subunits have also been implicated in interactions 
with RBCs. Residues 1052 to 1166 (in MSP-1D numbering) of the 
p38 subunit, encompassing H31 and part of H30 and H32 (Fig. 8A), were 
shown to specifically bind erythrocytes via an unknown mechanism 
independent of GPA and sialic acid, a negatively charged sugar 
moiety abundant on the erythrocyte surface (36). While the RBC 
target remained unclear (36), strongly basic patches present on 
H30 to H32 near the bottom of the MSP-1 cavity (Fig. 6) suggest that 
long-range electrostatic interactions with other erythrocyte compo-
nents could play a role. When recombinantly produced, this part of 
the p38 domain was recognized by sera of semi-immune individu-
als (36). Notably, the recombinant p38 fragment and polyclonal 
antibodies against it could inhibit parasite invasion of RBCs in vitro 
by nearly 70 and 90%, respectively (36), suggesting that it plays an 
important role in Plasmodium infectivity. Furthermore, semicon-
served B cell epitopes putatively associated with parasite growth 
inhibition in vitro were also identified on H30 and H32 in the study 
by Blank et al. (9) (Fig. 7). The p38 subunit, as well as the p42 sub-
unit, was further shown to interact with specific peptides of the 
erythrocyte anion transporter band 3 (37). These band 3 peptides 
appeared to have higher affinity for p42 and, in particular, for the 
p19 domain than for p38 (37). Considering that band 3 is the most 
abundant protein on the erythrocyte surface and essential in the 
merozoite invasion process, these interactions may be highly im-
portant for parasite attachment, although a molecular mechanism 
or precise MSP-1 binding site remains unclear (37).
Besides its interaction with band 3 (37), the p42 subunit has been 
reported to bind highly negatively charged heparin-like polysaccha-
rides, which are abundant on the erythrocyte surface (22). The 
resolved part of the p42 subunit (p33) contains two strongly basic 
patches on H35 and at the bottom of H36 to H37 (Fig. 6), which may 
play a role in heparin binding; the latter patch coincides with a 
semiconserved B cell epitope putatively associated with parasite 
growth inhibition (Fig. 7), supporting its functional importance (9).
In addition to these erythrocyte surface targets important for 
parasite invasion, MSP-1 has also been shown to play a role in 
egress through interaction with the erythrocyte cytoskeleton pro-
tein spectrin (24, 25). A previous study using a recombinant frag-
ment of p83 (encompassing H2 to H10) identified residues 291 to 344 
(in MSP-1D numbering), corresponding to H9 and H10 (Fig. 8A) 
as the binding site for spectrin (24). However, interactions with other 
subunits were not investigated (24), and the highly negatively charged 
spectrin could be expected to also interact with positively charged 
patches present elsewhere on the MSP-1 complex. As stated above, 
the resolved parts of p42 and p38 appear to adopt a BAR/IMD-like 
or STAT-like t-snare fold (fig. S5), which is associated with mem-
brane and cytoskeleton interactions, and the most extensive posi-
tively charged surface region of MSP-1 is found on this domain 
(Fig. 6). The recombinant (hd)MSP-1 used here also bound spectrin 
(Fig. 8B), and in the presence of spectrin, hdMSP-1 appeared to 
dimerize less readily than in its absence (1.7 ± 0.9 M versus 80 ± 
20 nM, respectively; Fig. 8C), suggesting that spectrin may compete 
for the dimerization interface. This interface includes not only H37 
of the p42 BAR/IMD-like coiled-coil domain but also H14 (p83), 
which is likewise part of a coiled-coil bundle (fig. S5) and contains a 
positively charged region (Fig. 6). MSP-1 has been linked to PVM 
rupture in the parasite egress pathway (24,  25,  38). Immuno-EM 
previously identified MSP-1 in high abundance on the PVM in re-
gions where the parasite and RBC membrane were apparently in 
contact (24). Furthermore, inhibition of SUB-1 has been shown to 
prevent the MSP-1–spectrin interaction (25) and PVM rupture 
(38). Thus, the MSP-1–spectrin interaction may play a role in PVM 
rupture, and given their fold, it is possible that the coiled-coil regions 
A
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Fig. 5. Dimerization of MSP-1. (A) Dimerization affinity for (hd)MSP-1 was deter-
mined by MST. KD values of 30 ± 20 nM (n = 3) and 60 ± 10 nM (n = 4) were found 
for MSP-1 and hdMSP-1, respectively. No significant dimerization was observed for 
heat-denatured MSP-1. Error bars represent SD. (B) Dimerization is mediated mainly 
through two symmetric interfaces (highlighted). (C and D) More detailed views of 
the dimerization interfaces. Salt bridges and H bonds are indicated by dashed 
lines. (E) Sequence alignment of residue pairs contributing to the dimerization in-
terface is given for the MSP-1D sequence used here and other P. falciparum iso-
lates, as well as other Plasmodium species. Full-sequence alignments can be found 
in figs. S6 and S7.
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Fig. 6. Electrostatic surface potential. MSP-1 model colored by electrostatic surface potential, where blue and red correspond to positive and negatively charged re-
gions, respectively. Insets show same view of the model in cylinder representation for reference.
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Fig. 7. Immunogenic epitopes. Immunogenic B cell epitopes identified in an MSP-1 vaccine trial (9) are mapped onto MSP-1. On the basis of correlation between IgG 
responses and parasite growth inhibition assay (GIA) activity of the various investigated sera, Blank et al. (9) identified epitopes putatively associated with GIA activity. 
Blue, no role; red, possible role in inhibiting parasite growth. Colored ovals indicate the degree of sequence conservation for each epitope: Dark purple, light purple, 
white, and green correspond to conserved, semiconserved (>50% conserved residues, rest dimorphic), mostly dimorphic (<50% conserved residues, rest dimorphic), and 
nonconserved epitopes. Dotted lines represent unresolved loops (scaled 1/3.5 relative to ribbon). More details can be found in fig. S9. aa, amino acids.
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of MSP-1 are involved in this mechanism. Note that Das and 
co-workers (25) previously reported that cleavage of the p38/p42 
processing site was necessary for binding of MSP-1 to inside-out 
erythrocyte ghost vesicles, which was attributed to interactions with 
spectrin, while we observe binding of spectrin to hdMSP-1 in which 
this processing site is not cleaved. The reason for this discrepancy 
could lie in experimental differences but remains unclear.
While we can only speculate about the molecular mechanism of 
these interactions, the flexibility of MSP-1 and, in particular, its 
wing domain may be central to its role as a major interaction sur-
face for these various erythrocyte proteins as well as other MSPs. 
That the previously reported B cell epitopes putatively associated 
with in vitro parasite growth inhibition can be mapped to various 
regions of the 3D structure (Fig. 7) suggests a multifaceted mode of 
interaction. As previously discussed, this ability of MSP-1 to bind 
multiple erythrocyte targets via seemingly different and redundant 
mechanisms might enhance the efficiency of erythrocyte attach-
ment and allow evasion of host cell immune responses (14, 37).
DISCUSSION
In summary, this work defines the architecture of MSP-1, the most 
abundant antigen on the erythrocyte-invading malaria parasite sur-
face. The protein appears to be flexible and adopts an unusual fold 
with a large central cavity, which may be fundamental to its pro-
posed role as a major hub for interaction with other MSPs and 
erythrocyte surface proteins. Previously identified RBC interaction 
sites could be mapped onto the flexible domain, as well as a strong-
ly basic region in the central cavity. This and other resolved basic 
patches could also play a role in initial weak adhesion to erythro-
cytes via long-range electrostatic interactions, e.g., with highly neg-
atively charged heparin-like polysaccharides, which are abundant 
on the erythrocyte surface. Notably, the coiled-coil fold of the p38 
and p42 subunits hints at a role in membrane remodeling or cyto-
skeleton interactions, which has indeed been proposed previously 
for MSP-1 (24, 25). Dimerization of MSP-1, which involves coiled-
coil regions, is hampered by the presence of spectrin, supporting 
this hypothesis. The structures presented here only form a small 
piece of the puzzle, given that MSP-1 forms a complex with other 
MSPs on the parasite surface. Nevertheless, the high-resolution de-
tail afforded by our models provides an important framework to 
guide future work to fully elucidate the role of the native MSP-1 




MSP-1 was produced recombinantly in Escherichia coli and purified 
under GMP-compatible conditions by Biomeva GmbH (Heidelberg, 
Germany) using the P. falciparum MSP-1D construct described by 
Kauth et al. (28). Briefly, the coding sequence of MSP-1D is largely 
based on the P. falciparum strain 3D7, but the N-terminal signal 
peptide and the C-terminal GPI anchor have been removed. The 
coding sequence was split into two halves (p83/30 and p38/42); each 
was expressed individually in E. coli W3110-Z1 and recovered as 
inclusion bodies. The recombinant MSP-1D was reconstituted as a 
heterodimer (hdMSP-1) in a process called “pulse renaturation” 
(39). The protein was purified using ion exchange and hydroxyapa-
tite chromatography followed by dialysis into phosphate-buffered 
saline (PBS) and lyophilization. MSP-1 produced in this way was 
previously shown to assemble in the same manner as the native 
MSP-1 complex (28) (density observed for a disulfide bond between 
C813 and C845  in our EM maps and the proximity of C211 and 
C216 in the maps are also indicative of native folding). Before use, 
lyophilized hdMSP-1 was reconstituted by adding ddH2O, filtered 
through a 0.22-m pore centrifugal filter, and subjected to SEC at 
4°C on a Superdex 200 Increase 10/300 column (GE Healthcare) 
equilibrated with gel filtration buffer [25 mM Hepes and 125 mM 
NaCl (pH 7.4)]. SEC peak fractions were pooled and concentrated 
to ~0.7 to 2.5 mg/ml using an Amicon Ultra centrifugal concentra-
tor [molecular weight cutoff (MWCO) 100,000; Merck]. For the 
production of fully SUB-1–cleaved MSP-1, hdMSP-1 was pro-
cessed in vitro following the procedure published by Koussis et al. 
(40). Lyophilized hdMSP-1 was reconstituted by adding ddH2O 
and dialyzed into SUB-1 buffer [50 mM tris and 15 mM CaCl 
(pH 7.6)]. After dialysis, precipitated protein was removed by cen-
trifugation. Recombinant P. falciparum SUB-1 (SUB-1), provided 
by M. J. Blackman, was added to hdMSP-1 in SUB-1 buffer, and the 
sample was incubated at 16°C overnight. Nonspecific cleavage and 
protein degradation were prevented by adding the protease inhibi-
tors E64, leupeptin, and Pefabloc. Successful processing was verified 
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Fig. 8. Interaction surfaces. (A) Various regions of MSP-1 that have been shown to interact with erythrocyte targets (15, 23–25) are indicated. Note that the MSP-1 regions 
were identified in studies using MSP-1 fragments, and other MSP-1 areas might also interact with the named targets. See main text for details. (B) MSP-1 was shown to 
bind spectrin using MST. KD values of 31 ± 5 nM (n = 4, red squares) and 100 ± 10 nM (n = 2, blue triangles) were found for the hdMSP-1–spectrin and MSP-1–spectrin com-
plexes, respectively. No significant binding of MSP-1 to heat-denatured spectrin was observed (gray circles). (C) MST analysis of the dimerization affinity for hdMSP-1 in 
the absence (red squares) and presence (blue triangles) of 100 nM unlabeled spectrin yielded KD values of 80 ± 20 nM (n = 2) and 1.7 ± 0.9 M (n = 2), respectively. Error 
bars represent SD.
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by SDS-PAGE. The processed sample was filtered through a 0.22-m 
pore centrifugal filter and again subjected to SEC at 4°C on a Superdex 
200 Increase 10/300 column equilibrated with gel filtration buffer. 
SEC peak fractions were pooled and concentrated to ~1.6 to 2.7 mg/
ml using an Amicon Ultra centrifugal concentrator (MWCO 3000).
EM sample preparation and cryo-EM data collection
Concentrated hdMSP-1 and fully processed MSP-1 SEC peak frac-
tions were diluted to ~0.02 mg/ml and examined by uranyl formate 
negative staining using a Tecnai Spirit BioTWIN electron microscope 
at 120 kV to confirm sample homogeneity. For cryo-EM, Quantifoil 
R2/2 and R1.2/1.3 holey carbon grids (copper and gold 300 mesh, 
respectively) were washed in chloroform overnight before use. Grids 
were prepared in the presence and absence of 0.125% (w/v) CHAPS 
(3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate) 
[0.25-fold CMC (critical micelle concentration)], which was added 
right before freezing. Grids were plasma-cleaned under an Ar/O2 
atmosphere at a ratio of 95:5, at 35 W for 35 s (NanoClean, model 
1070, Fischione Instruments), after which 3 l of sample was ap-
plied to the grids. Grids were blotted for 4 to 5 s with a blot force of 
20 at 100% humidity and 10°C and then plunge-frozen in liquid 
ethane using a using a Mark IV Vitrobot. The grids were screened, 
and data were collected at a pixel size of 1.077 Å (for hdMSP-1) or 
1.073 Å (for MSP-1) on a Titan Krios electron microscope (Thermo 
Fisher Scientific) operated at 300 kV equipped with a Quantum 
energy filter and a K2 camera (Gatan) at the Max Planck Institute 
of Biophysics. For hdMSP-1, four datasets were collected with the 
same imaging conditions and combined (fig. S2B and table S1): two 
in the absence of CHAPS and two in the presence of CHAPS, one of 
which was collected at a fixed tilt angle of 15° (all from R2/2 holey 
carbon copper mesh grids). For fully processed MSP-1, one dataset 
was collected from an R1.2/1.3 holey carbon gold mesh grid pre-
pared in the presence of CHAPS. Further data collection details are 
given in table S1.
Image processing
During data collection, datasets were preprocessed “on-the-fly” 
using Warp (41) for frame alignment, contrast transfer function 
(CTF) estimation, and particle picking; cryoSPARC (42) was used 
for 2D classification to monitor data quality including particle 
orientation and integrity. Of the 3978 original motion-corrected 
movies of the MSP-1 dataset, 3735 micrographs were used in pro-
cessing, using Warp (41) to curate the dataset; micrographs con-
taining signal at 3.9 Å or better, with estimated defocus values 
ranging from −0.5 to −3.0 m, and average motion in the first one-
third of the frames of no more than 1.5 Å per frame were retained. 
Subsequently, data were imported into RELION 3.0 (43). Motion 
correction and dose weighting were performed with MotionCor2 
(44) using a 5 × 5 patch. CTF estimation was performed with 
CTFFIND 4.1 (45), after which ~1.6 million particles picked by 
Warp (41) were extracted using a box size of 288 pixels at 1.073 Å 
per pixel. The particle set was imported into cryoSPARC (42) and 
cleaned by 2D classification. A minority of the 2D classes (4.4% of 
particles) corresponded to dimeric MSP-1 and was also excluded. 
The cleaned particle set was subjected to 3D heterogeneous refine-
ment (classification) using a 3D reference generated ab initio using 
cryoSPARC (42) from ~15,000 particles picked and preprocessed 
on-the-fly by Warp (41) during data collection. The resulting 3D 
classes (mostly defined by different conformations of the wing 
domain) were subjected to nonuniform (NU) refinement, followed 
by further cleaning by 2D and 3D classification. Particle star files 
were generated for the resulting particle sets using UCSF pyem 
(46), which were reimported into RELION 3.0 (43) and subject-
ed to iterative CTF refinement, 3D refinement, and Bayesian polishing 
until no further improvements in the EM maps were observed. Par-
ticle sets were then imported into cryoSPARC (42), subjected to 2D 
classification (which identified residual junk particles in only two 
cases) and final NU 3D refinement, resulting in six maps with nominal 
resolutions ranging from 3.1 to 3.6 Å (auto-tightened masked ap-
plied). The highest-resolution map was designated the “main” con-
formation. The alternative conformations (Alt conf) were numbered 
according to the position of the wing domain, from furthest (1) to 
closest (5) to the coiled-coil domain (the main conformation rep-
resents an intermediate position; see fig. S2A). To improve the res-
olution in the wing domain to aid model building, local refinement 
was performed in cryoSPARC (42) using the particle set corre-
sponding to the main conformation. To this end, soft masks en-
compassing either H1-12 (wing domain) or H13-37 (“rest”) were 
generated in RELION 3.0 (43) using a map generated from the ini-
tially built atomic model in UCSF chimera (47) filtered to 12 Å. For 
local refinement of the wing domain, placing the fulcrum at the tip 
of the wing domain at the end of helices H10 and H11 gave the best 
results. For local refinement of the rest of the map, density corre-
sponding to the wing domain was subtracted, and the fulcrum for 
refinement was placed at the center of mass of the mask. A graphical 
representation of the processing strategy used for the MSP-1 dataset 
is provided in fig. S2A.
For hdMSP-1, the four datasets were initially processed individ-
ually. Collected movies were curated either manually based on 
resolution estimates from CTFFIND 4.1 (45) and visual inspection 
(dataset 1) or using Warp (41). For dataset 1, 1686 of 2272 micro-
graphs containing signal at 5 Å or better were retained. For dataset 2, 
3560 of 4725 micrographs were retained, containing signal at 5.2 Å 
or better, with estimated defocus values ranging from −0.3 to −3 m, 
and average motion in the first one-third of the frames of no more 
than 2 Å per frame. For dataset 3, 5864 of 6610 micrographs were 
retained, containing signal at 3.9 Å or better, with estimated defocus 
values ranging from −0.3 to −2.5 m, and average motion in the 
first one-third of the frames of no more than 1 Å oer frame. For 
dataset 4, 1391 of 1454 micrographs were retained, containing signal 
at 5 Å or better, with estimated defocus values ranging from −0.75 
to −3 m, and average motion in the first one-third of the frames of 
no more than 1 Å per frame. Subsequently, data were imported into 
RELION 3.0 (43). Motion correction and dose weighting were per-
formed with MotionCor2 (44) using a 5 × 5 patch. CTF estimation 
was performed with CTFFIND 4.1 (45). Particle picking was per-
formed using crYOLO (48) for dataset 1 (yielding ~219,000 parti-
cles) and Warp (41) for all other datasets (yielding ~696,000, 
~1.2 million, and ~ 304,000 particles for datasets 2 to 4, respectively). 
Particles were extracted using a box size of 288 pixels at 1.077 Å per 
pixel. Various processing strategies were tested for all datasets, and 
those resulting in the best maps were eventually followed; a graphi-
cal representation of the final processing strategy is provided in fig. 
S2B. Datasets were either first cleaned by 2D classification using 
ISAC from the SPHIRE cryo-EM software suite (49) or subjected 
directly to 3D classification in RELION 3.0 (43) using either un-
binned data (box size, 288 pixels) or 4× binned data (box size, 
72 pixels). Further rounds of 3D classification in RELION 3.0 (43) 
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were performed if necessary, followed by iterative CTF refine-
ment, 3D refinement, and Bayesian polishing, until no further im-
provements to the maps were observed. Particles sets were then 
refined in 3D applying C2 symmetry (after having confirmed the 
symmetry in a 3D reconstruction without applying symmetry). No 
differences were observed in the final reconstructions of the four 
datasets at the obtained resolution beyond differences in the angu-
lar orientation distribution of the particles (fig. S2B), and thus, all 
particle sets were merged. Excluding any of the four datasets result-
ed in (slightly) worse final maps in subsequent processing steps. To 
better classify the conformational variability observed in the wing 
domain, the combined particle sets were subjected to symmetry ex-
pansion (50) and signal subtraction yielding a particle set corre-
sponding to all monomers. The monomer mask used for signal 
subtraction was created in RELION 3.0 (43) using a monomer map 
generated from a dimer map in USCF Chimera (47) using the vol-
ume eraser tool. Further 3D classification without alignment into 
10 classes using a monomer mask was performed. The best classes 
were refined individually in RELION 3.0 (43) yielding monomer 
maps with two distinct conformations of the wing domain. In a sec-
ond approach, to get the best possible dimer maps, the best classes 
were also merged. Signal subtraction was reverted, and duplicates 
were removed. The resulting particle set was refined in 3D and sub-
jected to 3D variability analysis in cryoSPARC (see movie S1) (51). 
Two extreme conformations were extracted from the trajectory of 
the first mode of the variability analysis and used as references for 
multi-referenced 3D classification in cryoSPARC (42). This re-
sulted in two maps with wing domain conformations similar to 
those obtained from RELION (requesting further classes supplying 
more references did not yield any additional good maps). Local res-
olution estimation of the maps was performed using cryoSPARC 
(42), except for the symmetry expansion–derived maps for which 
RELION 3.0 (43) was used. UCSF pyem (46) was used to generate 
Euler angle distribution plots for 3D reconstructions generated in 
cryoSPARC (42). All reconstructed maps had the wrong handed-
ness and were flipped for atomic model building.
Model building and analysis
Buccaneer (52) was used to start de novo model building followed 
by manual building in Coot (53) guided by PSIPRED 4.0 (54) sec-
ondary structure prediction, using either RELION 3.0 (43) with 
automatic B-factor estimation to sharpen the maps or the auto- 
sharpened refined maps resulting from NU refinement in cryo-
SPARC (42). DeepEMhancer was also used to postprocess the map 
corresponding to the main conformation of MSP-1 (55). The local-
ly refined maps [auto-sharpened in cryoSPARC (42) or sharpened 
using DeepEMhancer (55)] were also used in model building of the 
main conformation of MSP-1. For hdMSP-1, the C2 symmetric 
dimer maps showed higher local resolution for most of the protein, 
while the monomer maps obtained from the symmetry-expanded 
particle set showed a better-resolved wing domain (figs. S2 to S4) 
and were used to build that part. PHENIX (56) was used for model 
refinement, and the model was scored with Molprobity (57). The 
refined model was then used to locally sharpen the refined EM map 
using LocScale (58). The LocScale-sharpened EM map was subse-
quently used in combination with the other maps for further itera-
tive refinement in Coot (53), ISOLDE (59), and PHENIX (56). The 
best resolved conformation for each sample was built initially, and the 
resulting atomic model was fit into the maps of the other conformation(s) 
using ISOLDE (59). Interhelical interactions of the flexible wing do-
main were restrained until the model had settled into the density of 
the alternative conformation, after which restraints were released 
and further iterative refinement in Coot (53), ISOLDE (59), and PHENIX 
(56) was performed. After confirming that the independently built 
MSP-1 and hdMSP-1 models did not differ substantially, the wing 
domain built for the main conformation of MSP-1 was fit into the 
hdMSP-1 maps and refined in the same manner. Map-model FSC 
(Fourier shell correlation) curves were generated using PHENIX (56). 
The model was refined in the same manner against one of the inde-
pendent half-maps and cross-validated against the both independent 
half-maps; the overlay of the resulting map-model FSCs indicated that 
no overrefinement took place. Further model quality statistics were 
determined using PHENIX (56) and can be found in table S1. Structur-
al figures were prepared using USCF Chimera (47), USCF ChimeraX 
(60), and Inkscape. An initial topology cartoon was generated by 
Pro-Origami (61) and modified in Inkscape. The ConSurf webserver 
(62) and UCSF Chimera (47) were used to map the MSP-1 sequence 
conservation onto the derived structure using a sequence align-
ment of all Plasmodium MSP-1 genes available from PlasmoDB (63) 
generated by Clustal Omega 1.2.4 (64). The PBDsum webserver 
(65) and UCSF Chimera (47) were used to analyze the dimerization 
interface. The FATCAT webserver (31) was used to identify known 
structural motifs in the determined MSP-1 structure.
Cross-linking mass spectrometry
Cross-linking combined with mass spectrometry (MS) analysis was 
used to validate the MSP-1 model. Lyophilized hdMSP-1 (150 g) was 
reconstituted by adding 150 l of ddH2O, followed by buffer exchange 
into PBS. A stock solution of disuccinimidyl sulfoxide (DSSO; 
Thermo Fisher Scientific) was freshly prepared according to the 
manufacturer’s instructions. After optimizing the cross-linker concen-
tration by analyzing cross-linked hdMSP-1 by SDS-PAGE, hdMSP-1 
was incubated with a 20-fold molar excess of DSSO for 60 min at 
room temperature before stopping the reaction with quenching 
buffer. Samples were digested in urea lysis buffer [8 M urea, 100 mM 
NaCl, and 50 mM triethylamonium bicarbonate (TEAB) (pH 8.5)] 
using a two-stage Lys-C and trypsin digestion protocol. Samples were 
reduced and alkylated using 10 mM dithiothreitol (1 hour, 27°C) 
and 30 mM iodacetamide (30 min, room temperature, in the dark). 
Lys-C was added at a 1:100 enzyme-to-protein molar ratio, and the 
sample was incubated at 37°C for 4 hours. Afterward, the sample 
was diluted 1:5 using 50 mM TEAB. Trypsin was added at a 1:50 
enzyme-to-protein molar ratio, and samples were incubated over-
night at 37°C. Digestion was stopped by acidification [0.6% (v/v) 
trifluoroacetic acid (TFA)] before desalting using StageTips (66). 
Dried peptides were resuspended in reconstitution buffer (2.5% 
1,1,1,3,3,3-hexafluoro-2-propanol and 0.1% TFA in water) before 
liquid chromatography (LC)–MS measurement, which was conducted 
using an ultra-performance liquid chromatography system (Ultimate 
3000 UPLC) (Thermo Fisher Scientific) coupled to an Q-Exactive 
HF-X mass spectrometer (Thermo Fisher Scientific). During the LC 
separation, the peptides were first loaded onto a trapping cartridge 
(Acclaim PepMap300 C18, 5 m, 300-Å-wide pore; Thermo Fisher 
Scientific) and washed for 3 min with 0.1% TFA in water. Analytical 
separation was performed using a nanoEase MZ Peptide analytical col-
umn (300 Å, 1.7 m, 75 m by 200 mm; Waters) and carried out 
for 90-min total analysis time. The 90-min LC method consisted 
of a multistep gradient going from 2 to 8% solvent B (80% acetonitrile 
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and 20% water with 0.1% formic acid) in 5 min, 8 to 25% in 45 min, 
and 25 to 40% in 10 min followed by a washing and an equilibration 
step while solvent A was water and 0.1% formic acid. Eluting pep-
tides were analyzed online by a coupled Q-Exactive-HF-X mass 
spectrometer running in data-dependent acquisition mode. Full 
scans were performed at 120K resolution on a mass range covering 
375 to 1500 mass/charge ratio (m/z) with a maximum allowed in-
jection time (maxIT) of 54 ms, followed by up to 8 tandem mass 
spectrometry (MS/MS) scans at 60K resolution with a maxIT of 
100 ms for up to 1 × 105 ions [automatic gain control (AGC) target]. 
Precursors were isolated with a window of 1.6 m/z and fragmented 
with a collision energy of 30 NCE (normalized collision energy). 
Unassigned, singly and doubly charged features were excluded 
from fragmentation, and dynamic exclusion was set to 10 s. Raw 
files were converted into mzML files using default settings in 
MSConvert (v3.0.21048) from the ProteoWizard toolkit (67). mzML 
files were then analyzed using Merox (v2.0.1.4.) (68) for identifica-
tion of cross-linked peptides using a single protein database of the 
MSP-1D protein. Overall, default search parameters were used with 
the following changes: Cross-linker was set to DSSO, lysines were 
set as cross-linking sites, consecutive peptides were ignored as 
cross-linkers, and analysis mode was set to “quadratic mode” as rec-
ommended for small fasta files. A 1% false discovery rate cutoff was 
used including manual inspection of lower-scoring hits. The result-
ing table was exported as csv and used for 3D structural analysis 
using R and ChimeraX (60).
Thermostability and MST characterization
The thermal stability and aggregation behavior of (hd)MSP-1 were 
investigated using nanoscale differential scanning fluorimetry 
(nanoDSF) on a Prometheus NT.48 instrument (NanoTemper 
Technologies). Samples obtained after SEC were concentrated to ~0.7 
to 2.7 mg/ml and loaded into nanoDSF-grade standard capillaries 
(NanoTemper Technologies). Samples were heated from 15 to 
95°C at 1°C/min, and the intrinsic fluorescence at  = 330 nm after 
excitation at  = 280 nm and scattering were used to monitor recep-
tor denaturation and aggregation, respectively. Relatively high pro-
tein concentrations were needed because of the lack of Trp residues 
in MSP-1. The first derivative of the unfolding curves was used to 
determine the transition midpoint using PR.ThermControl soft-
ware (NanoTemper Technologies).
The affinity of spectrin for MSP-1 was assessed by MST. Spectrin 
(Sigma-Aldrich) was labeled with NT-647-NHS dye (NanoTemper 
Technologies), as per the manufacturer’s instructions, and added to 
a dilution series of unlabeled MSP-1 (61 nM to 2 M, final concen-
trations) in 25 mM Hepes and 125 mM NaCl (pH 7.4), supplemented 
with 0.05% (w/v) Tween-20 (final concentration) using LoBind 
tubes (Eppendorf) to prevent adsorption of the sample. The KD of 
the MSP-1 dimer was also assessed by MST. MSP-1 was labeled 
with NT-647-NHS dye (NanoTemper Technologies) as per the 
manufacturer’s instructions. Labeled MSP-1 (final concentration of 
8 nM for fully processed MSP-1 and 10 nM for hdMSP-1) was added 
to a dilution series of unlabeled MSP-1 (61 pM to 2 M), in the 
presence or absence of 100 nM spectrin (final concentrations) in 
25 mM Hepes and 125 mM NaCl (pH 7.4), supplemented with 
0.05% (w/v) Tween-20 (final concentration) using LoBind tubes 
(Eppendorf). Under these conditions, the fluorescence was found to 
be constant (within ±10%) for all points in the titration curves in all 
experiments. The samples were loaded into premium coated capillaries 
(NanoTemper Technologies). MST experiments were carried out 
on a blue/red Monolith NT.115 instrument (NanoTemper Tech-
nologies) using the red filter set, an excitation power of 100%, and 
an MST power of 40 or 60%; 60% MST power gave the best re-
sults (highest signal-to-noise ratio) in all cases except for the titra-
tion of hdMSP-1 against labeled spectrin, where both MST powers 
gave comparably good results and 40% was used. MST data were 
analyzed in MO.Affinity Analysis software (NanoTemper Technol-
ogies), using −1 to 0 s before the infrared (IR) laser was turned on as 
the cold region and 19 to 20 s after the IR laser was turned on as the 
hot region, except for the titration of hdMSP-1 against labeled spectrin, 
where 0.2 to 1.2 s after the IR laser was turned on was used as the hot 
region. Data were plotted using Origin Pro 2015 (Origin Lab).
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